Irvine Scientific sluit distributieovereenkomst met Biotech Inc. over vitrificatie-instrument CRYOLOCK
SANTA ANA, Calif.–(BUSINESS WIRE)– Irvine Scientific, wereldleider in productie en vernieuwing van technologieën voor kunstmatige bevruchting, heeft vandaag een nieuwe samenwerkingsovereenkomst met Biotech Inc. aangekondigd. Krachtens de overeenkomst krijgt Irvine Scientific de exclusieve distributierechten voor het vitrificatie-instrument CRYOLOCK™ in een aantal landen.
Irvine Scientific werkt met toewijding aan een geheel systematische aanpak op basis van oplossingen, door hoogwaardige media voor vitrificatie embryo’s en oöcyten in combinatie met goedgekeurde instrumenten aan te bieden. CRYOLOCK is in korte tijd uitgegroeid tot een van de meest gerespecteerde apparaten voor vitrificatie in IVF-laboratoria. De nieuwe samenwerking stelt Irvine Scientific in staat
Irvine Scientific Announces New Partnership with Biotech Inc., to Distribute CRYOLOCK Vitrification Device
SANTA ANA, Calif.–(BUSINESS WIRE)– Irvine Scientific ®, a world leader in the innovation and manufacture of Assisted Reproductive Technologies (ART), today announced a new partnership agreement with Biotech Inc., giving Irvine Scientific exclusive distribution rights for the CRYOLOCK™ vitrification device in selected countries worldwide.
Irvine Scientific is committed to providing a total system solutions approach by offering high quality vitrification media used for oocytes and embryos of all stages along with approved devices. CRYOLOCK has rapidly become one of the most highly respected vitrification devices in IVF laboratories. This new partnership enables Irvine Scientific to expand its support of approved vitrification devices.
“We are confident that the addition of CRYOLOCK will allow us to support laboratories that prefer this proven and widely used device. We are excited to provide an expanded set of vitrification devices to help customers achieve exceptional results.” said Yuichi Nagano, President and CEO, Irvine Scientific.
“This partnership significantly strengthens the existing CRYOLOCK device and demonstrates Biotech Inc.’s commitment to expanding this exceptional product for use worldwide to the infertility market”, said Jorge Parra, CRYOLOCK designer and CEO, Biotech, Inc.
Learn more about the entire line of products for Assisted Reproductive Technology at http://www.irvinesci.com/assisted-reproductive-technology
ENDS
Notes to Editors
About Irvine Scientific
Irvine Scientific, a member of JX Group, is a worldwide leader in the innovation and manufacture of cell culture media, reagents, and medical devices for researchers and clinicians. The company provides unrivalled service and quality to scientists working in cell therapy and regenerative medicine, assisted reproductive technology and cytogenetics, and industrial cell culture for the large-scale production of biotherapeutics and vaccines. Irvine Scientific adheres to both ISO and FDA regulations and operates dual cGMP manufacturing facilities in California, USA and Tokyo, Japan. The company’s consultative philosophy combined with expertise in cell culture and compliance provides customers with unique capabilities and support. For over 40 years, Irvine Scientific has remained uniquely flexible and focused on media while becoming a strategic global leader in media products and services.
About Biotech Inc.,
Established in July 2006, Biotech Inc, produces and designs instruments and tools for laboratory use in bioscience research. The Company is ISO 13485:2003 registered as a Medical Device Manufacture Company following CE Mark and FDA regulations, Biotech Inc focuses on providing high quality products with exceptional customer service in order to meet the needs of the final user
View source version on businesswire.com: http://www.businesswire.com/news/home/20151016005232/en/
Contacts
Irvine Scientific
Lori Serles
Phone: 949-261-7800 x145
Email: lserles@irvinesci.com
or
Zyme Communications
Lorna Cuddon
Phone: +44 (0)7811996942
Email: lorna.cuddon@zymecommunication s.com